PINK1-mediated mitophagy confers cancer cells with the ability to survive chemotherapy, whereas inhibiting mitophagy restores chemosensitivity in chemotherapy-treated ESCC cells (Yamashita et al., 2017). This evidence concerns the gene PINK1 and esophageal squamous cell carcinoma.